The Transparency Commission (CT), under HAS, assesses the clinical efficacy and actual benefit of medicines. Its opinions determine reimbursement eligibility and coverage levels by national health insurance.
CT plays a key role in regulating access to innovative treatments in France.
FIND US
Aroma, Parc d’activités, 45 Bd Marcel Pagnol, 06130 Grasse
Mon-Fri: 9:00 AM – 6:00 PM
Discover our main services to help you address the French Market.
Market Access
The Exploitant Status
Post Market Surveillance
Supply Chain Optimization
Promotion & Sales
We operate in the following areas of expertise.
Orphan Drugs
Hospital Market
Blood Derived products
ATMPs
Regulatory Compliance
